Growth Metrics

Profound Medical (PROF) Current Deferred Revenue (2018 - 2026)

Profound Medical's quarterly Current Deferred Revenue came in at $464000.0 in Q1 2026, down 27.04% year-on-year from $636000.0 in Q1 2025, and up 4.27% quarter-over-quarter from $445000.0 in Q4 2025.

Profound Medical has reported Current Deferred Revenue for 9 years, with the latest figure at $464000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Deferred Revenue fell 27.04% year-over-year to $464000.0; the trailing twelve-month figure through Mar 2026 stood at $464000.0 (down 27.04% YoY), and the FY2025 full-year result was $445000.0, up 6.21% from the prior year.
  • Current Deferred Revenue for Q1 2026 stood at $464000.0, up from $445000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $840000.0 in Q2 2022, with the low at $64000.0 in Q3 2024.
  • Average Current Deferred Revenue over 5 years is $446117.6, with a median of $445000.0 recorded in 2025.
  • Year-over-year, Current Deferred Revenue surged 2412.9% in 2022 and tumbled 81.17% in 2024.
  • Tracing PROF's Current Deferred Revenue over 5 years: stood at $471000.0 in 2022, then jumped by 54.56% to $728000.0 in 2023, then sank by 42.45% to $419000.0 in 2024, then rose by 6.21% to $445000.0 in 2025, then advanced by 4.27% to $464000.0 in 2026.
  • The last three Current Deferred Revenue figures came in at $464000.0 (Q1 2026), $445000.0 (Q4 2025), and $434000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Profound Medical 244.28 Mn 193.99 Mn 3.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 464,000.00
Dec 31, 2025 445,000.00
Sep 30, 2025 434,000.00
Jun 30, 2025 694,000.00
Mar 31, 2025 636,000.00
Dec 31, 2024 419,000.00
Sep 30, 2024 64,000.00
Jun 30, 2024 142,000.00
Mar 31, 2024 212,000.00
Dec 31, 2023 728,000.00
Sep 30, 2023 163,000.00
Jun 30, 2023 754,000.00
Mar 31, 2023 212,000.00
Dec 31, 2022 471,000.00
Sep 30, 2022 779,000.00
Jun 30, 2022 840,000.00
Mar 31, 2022 127,000.00
Dec 31, 2021 477,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 852,000.00
Mar 31, 2021 193,000.00
Dec 31, 2020 826.88
Sep 30, 2020 755,000.00
Jun 30, 2020 26,000.00
Mar 31, 2020 663,000.00
Dec 31, 2019 496,161.42
Sep 30, 2019 606,218.00
Jun 30, 2019 289,367.65
Mar 31, 2019 329,579.52
Dec 31, 2018 236,800.13